Nexperia has taken its own parent to court. The Dutch chipmaker filed suit at the Amsterdam District Court against Wingtech Technology, its controller Zhang Xuezheng, and the two Chinese Nexperia entities in Dongguan and Shanghai, claiming USD 2 billion plus statutory interest running from 1 October 2025.
Wingtech says it accepts neither the sum nor any of the allegations behind it.
A seizure first, an invoice second
On 30 September 2025 the Dutch government invoked a Cold War era statute to freeze Nexperia’s global assets on national security grounds. It suspended Zhang as chief executive and placed Wingtech’s controlling stake in the hands of a third party administrator.
What followed inside China was survival engineering. Cut off from Dutch and German wafer supply, Nexperia’s Chinese operation rebuilt its supplier base, lifting local content from under 20 per cent to 100 per cent. Wingtech is now pushing its process onto 12-inch wafer platforms with domestic foundry partners while the overseas business builds its own parallel supply chain.
The cost of that split showed up on the balance sheet. China Chengxin cut Wingtech’s issuer and bond ratings from BBB+ to BBB- on 15 September, with a negative outlook.
The claim arrived with a restructuring offer
The timing is the substance. On the evening of 3 November Wingtech disclosed a restructuring proposal from the Dutch administrators and rejected it in writing. The plan, which Wingtech calls the two circles arrangement, would leave the company full ownership of Nexperia’s China business while outside investors take control of the global operation, reducing Wingtech to a minority stake.
The USD 2 billion claim surfaced in the same window. Wingtech paid roughly RMB 34 billion for a global semiconductor asset. Under the proposal it would keep the Chinese half and hold a financial position in the rest.
Wingtech’s reply called the plan discriminatory against Chinese investors and described it, whatever procedural clothing it wears, as expropriation.
The delisting clock matters more than the claim
Wingtech has traded under delisting risk warning since 6 May 2026, after its 2025 annual report drew a disclaimer of opinion. The reason for that disclaimer is the same dispute. Auditors could not obtain data from the overseas Nexperia entities, so the business cannot be consolidated.
The rule is mechanical. Another disclaimer on the 2026 annual report triggers termination of listing.
The underlying economics are strange. Nexperia’s overseas operation booked USD 389 million of revenue in the third quarter of 2026 with healthy cash flow. Not one dollar of it reaches Wingtech’s consolidated accounts. Wingtech’s own nine-month revenue fell 93 per cent to RMB 2.05 billion, with a net loss of RMB 623 million.
At the end of September 2026 the company had about RMB 7.15 billion of unconverted convertible bonds against RMB 3.6 billion in cash and trading financial assets. The rating agency flagged rising liquidity risk if conversion stays weak.
What Wingtech still holds
Two instruments, neither decisive. The Dongguan Intermediate People’s Court has barred relevant parties from disposing of Nexperia’s equity, intellectual property and assets at home and abroad, with a RMB 100,000 daily penalty for breach. Separately, Wingtech has filed an international arbitration claim of about USD 8 billion against the Dutch state.
Domestic preservation freezes assets but does not restore control. Arbitration applies pressure at state level but does not fix an audit opinion. The two tracks run in parallel and cannot substitute for each other.
The administrators do not need to win USD 2 billion. They need the case to exist, so that uncertainty keeps eroding the one thing Wingtech cannot buy back, which is time.
Editor’s note: This is an adapted translation of the original Sohu Tech report. It has been trimmed and restructured for readability for an international business audience. The full original (in Chinese) is at https://www.sohu.com/a/1097233965_117917.